|
|
|
瑞銀(盧森堡)生化股票基金
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
788.78 |
-2.69 |
-0.34% |
2020/07/09 |
|
|
| 2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
| 14.32% |
1.85% |
32.71% |
54.62% |
41.28% |
1.57% |
-17.08% |
25.45% |
-13.98% |
29.08% |
| 瑞銀(盧森堡)生化股票基金(美元)
| |
本基金主要投資於全球生化科技產業中從事研究、產品開發、產品製造及配銷的公司股票;選股著重於個別公司之市場地位及該公司之管理與獲利能力，以獲得來自該產業的利益。本基金的投資目標在於透過積極的基金管理方式，達到最佳之投資績效，同時將投資風險降至最低。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2020/07/09 |
788.78 |
-0.34% |
2020/06/22 |
777.89 |
0.77% |
| 2020/07/08 |
791.47 |
0.44% |
2020/06/19 |
771.92 |
3.61% |
| 2020/07/07 |
788.02 |
1.36% |
2020/06/18 |
745.04 |
0.55% |
| 2020/07/06 |
777.41 |
0.47% |
2020/06/17 |
741.00 |
1.23% |
| 2020/07/02 |
773.81 |
0.77% |
2020/06/16 |
731.98 |
1.74% |
| 2020/07/01 |
767.88 |
0.59% |
2020/06/15 |
719.48 |
1.52% |
| 2020/06/30 |
763.34 |
1.38% |
2020/06/12 |
708.70 |
0.78% |
| 2020/06/29 |
752.94 |
-0.80% |
2020/06/11 |
703.24 |
-3.88% |
| 2020/06/26 |
759.05 |
-2.21% |
2020/06/10 |
731.63 |
0.62% |
| 2020/06/25 |
776.20 |
-0.22% |
2020/06/09 |
727.13 |
0.01% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
-0.34% |
1.93% |
8.48% |
28.44% |
18.91% |
35.02% |
20.30% |
| NBI生技指數 |
-1.06% |
0.54% |
4.51% |
22.21% |
15.51% |
28.31% |
15.51% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
-0.68% |
1.46% |
4.28% |
24.74% |
13.55% |
24.32% |
16.54% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
-0.22% |
-0.39% |
9.90% |
1.43% |
13.54% |
2.38% |
| MSCI 製藥指數 (price) |
0.00% |
-0.36% |
-2.18% |
5.73% |
-2.15% |
7.87% |
-1.64% |
| MSCI 生物科技指數 (price) |
0.00% |
0.22% |
4.71% |
16.20% |
14.69% |
36.75% |
16.33% |
|
-0.24% |
-0.68% |
-0.28% |
12.02% |
4.37% |
15.45% |
5.58% |
|
-0.25% |
-0.71% |
-0.33% |
11.74% |
3.86% |
14.29% |
5.03% |
|
0.06% |
1.24% |
6.43% |
19.06% |
14.70% |
30.93% |
15.88% |
|
-0.55% |
1.27% |
3.36% |
17.15% |
8.29% |
14.63% |
8.82% |
|
-1.13% |
-1.09% |
0.72% |
6.85% |
0.21% |
14.10% |
2.76% |
|
-1.31% |
-0.48% |
0.23% |
10.53% |
2.06% |
14.77% |
3.57% |
|
-0.15% |
-0.28% |
1.55% |
13.69% |
6.90% |
18.99% |
7.85% |
|
-0.62% |
0.28% |
2.36% |
13.86% |
7.64% |
10.18% |
8.17% |
|
-0.74% |
0.23% |
2.75% |
15.95% |
9.13% |
15.96% |
9.99% |
|
-3.19% |
4.87% |
14.90% |
33.54% |
12.98% |
44.64% |
10.56% |
|
0.10% |
-1.11% |
-0.43% |
4.21% |
-4.50% |
7.58% |
-2.03% |
|
-1.00% |
1.05% |
5.63% |
24.45% |
13.66% |
25.57% |
14.59% |
|
-1.01% |
1.00% |
5.54% |
24.05% |
12.89% |
23.90% |
13.80% |
|
-0.80% |
0.10% |
-0.71% |
11.10% |
-3.13% |
10.63% |
-2.33% |
|
-0.49% |
-0.34% |
2.75% |
15.48% |
5.03% |
15.90% |
5.05% |
|
-0.51% |
-0.36% |
2.67% |
15.17% |
4.51% |
14.73% |
4.48% |
|
-0.49% |
-0.41% |
2.58% |
15.10% |
3.81% |
12.86% |
3.75% |
|
-0.50% |
-0.39% |
2.67% |
15.32% |
4.20% |
13.70% |
4.17% |
|
-0.47% |
-0.31% |
2.83% |
15.73% |
5.43% |
16.79% |
5.48% |
|
-0.05% |
1.19% |
3.91% |
14.25% |
12.37% |
19.88% |
12.93% |
|
-1.16% |
1.26% |
5.48% |
22.05% |
14.43% |
22.94% |
15.70% |
|
-0.98% |
0.98% |
6.16% |
18.42% |
13.57% |
25.31% |
16.12% |
|
-1.16% |
1.28% |
5.61% |
22.51% |
15.67% |
26.06% |
17.02% |
|
-0.97% |
-0.24% |
0.20% |
13.73% |
-1.34% |
4.46% |
-0.93% |
|
-0.78% |
-0.51% |
0.84% |
10.33% |
-2.07% |
6.52% |
-0.55% |
|
-0.97% |
-0.21% |
0.31% |
14.14% |
-0.25% |
7.16% |
0.23% |
|
-0.85% |
-0.11% |
0.96% |
12.29% |
0.79% |
13.41% |
1.73% |
|
-0.49% |
0.50% |
2.36% |
12.83% |
8.98% |
24.13% |
10.16% |
|
-0.46% |
0.69% |
2.11% |
15.04% |
5.83% |
21.45% |
6.34% |
| 基金平均績效 |
-0.72% |
0.35% |
3.05% |
15.97% |
6.63% |
18.06% |
7.47% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
